Page-2 of SARS CoV 2

Vajra Kavach Disinfection System

June 1, 2021

Mumbai-based start-up, Indra water has developed “Vajra Kavach Disinfection System” which removes scourge of viral particles from equipment used by Corona warriors front line workers. About Disinfection System Disinfection System removes any possible traces of SARS-Cov-2 virus from Personal Protective ..

Month: 

DNA Vaccines Effective in Hamsters

May 28, 2021

Researchers from Taiwan developed a vaccine using DNA of coronavirus spike protein and tested its efficacy on Mice and Hamsters. This technique is different than mRNA vaccines. Highlights DNA vaccines are usually hard to deliver into cells. But, researchers from ..

Month: 

IIT Mandi reveals Key Protein Structure in Covid-19 Virus

May 28, 2021

Part of structure of a key protein in COVID-19 virus was revealed by researchers from Indian Institute of Technology, Mandi. How this study is significant? Covid-19 protein structure will help in understanding mode of action & its role in spread ..

Month: 

CCoV-HuPn-2018 Coronavirus

May 24, 2021

CCoV-HuPn-2018 coronavirus, with its origin in dogs, was detected among patients hospitalised with pneumonia in 2017-2018 in Malaysia. As per study, it may be the eighth unique coronavirus known cause disease in humans, once confirmed as pathogen.  However, it does ..

Month: 

CSIR-CSIO transfer UV Disinfection Technology Indigenous Manufacturers

May 24, 2021

CSIR-Central Scientific Instruments Organisation (CSIR-CSIO) has transferred the UV Disinfection technology to 28 indigenous manufacturers. UV Disinfection technology was developed by CSIR-CSIO to combat SARS-CoV-2 virus. Background UV Disinfection technology-V1.06 was developed by CSIR-CSIO, Chandigarh in a bid to prevent ..

Month: 

Pfizer-BioNTech to provide 2 billion Covid-19 vaccine to Poor Nations

May 23, 2021

In a bid to fulfil the international calls for vaccine solidarity, American pharmaceutical company, Pfizer and German company, BioNTech have pledged to provide 2 billion doses of Covid-19 vaccine to poor countries in middle-income and low-income countries in next 18 ..

Month: